The biopharmaceuticals excipients market is expected to grow at a CAGR of 12.2%.
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 162-page report you will receive 85 charts– all unavailable elsewhere.
The 162-page report provides clear detailed insight into the biopharmaceuticals excipients market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Biopharmaceuticals excipients market forecasts to 2030
• This report also breaks down the revenue forecast for the global pharmaceutical excipient market by product type (Solubilizers & Surfactants/Emulsifiers, Polyols, Carbohydrates, Speciality Biopharmaceutical Excipients)
• This report also breaks down the revenue forecast for the biopharmaceuticals excipients market by Polyols: • Mannitol • Sorbitol • Others
• This report also breaks down the revenue forecast for the biopharmaceuticals excipients market by carbohydrates: • Sucrose • Dextrose • Starch • Others
• This report provides individual revenue forecasts to 2030 for these regional and national markets: • North America: US and Canada • Europe: UK, France, Germany, Spain, Italy, Rest of Europe • APAC: China, India, Australia, Indonesia, South Korea, Rest of APAC • MEA • RoW
Each region is further broken down by product type
• Our study gives a SWOT & PEST Analysis
• Our study discusses the selected leading companies that are the major players in the biopharmaceuticals excipients market: • ABITEC Corp • Signet Chemical Corporation • Roquette Freres SA • Sigachi Industries • MEGGLE AG • & Other Companies
Visiongain’s study is intended for anyone requiring commercial analyses for the biopharmaceuticals excipients market. You find data, trends, and predictions.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1 Report Overview
1.1 Global Biopharmaceuticals Excipients Market Overview
1.2 Segmentation
1.3 Market Drivers, Restraints and Opportunities
1.4 Why You Should Read This Report
1.5 How This Report Delivers
1.6 Key Questions Answered by This Analytical Report Include:
1.7 Methodology
1.7.1 Secondary Research
1.7.2 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Introduction to the Biopharmaceuticals Excipients Market
Table 5.12 China Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
Table 5.13 Australia Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
Table 5.14 India Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
Table 5.15 Indonesia Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
Table 5.16 South Korea Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
Table 5.17 Rest of Asia Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
Table 5.18 Middle East Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
Table 5.19 Africa Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
Table 5.20 Rest of the World Biopharmaceuticals Excipients Market Forecast by Product 2020-2030 (US$m, AGR %, Cumulative)
Table 6.1 ABITEC CORP. 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
Table 6.2 Abitec Corp. Product Portfolio, 2020
Table 6.3 Signet Chemical Corporation Pvt. Ltd. 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
Table 6.4 Roquette Freres SA 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
Table 6.5 Roquette Freres SA Product Portfolio 2020
Table 6.6 Sigachi Industries Pvt. Ltd. 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
Table 6.8 Meggle AG 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
Table 6.9 Meggle AG Product Portfolio 2020
Table 6.10 Colorcon, Inc. 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
Table 6.11 Colorcon, Inc. Product Portfolio 2020
Table 6.12 DMV-Fonterra Excipients GmbH & Co. KG 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
Table 6.14 Clariant AG 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
Table 6.15 Clariant AG Product Portfolio 2020
Table 6.16 SPI Pharma Inc. 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
Table 6.17 SPI Product Portfolio 2020
Table 6.18 Pharmonix Biological Pvt. Ltd. 2020 (CEO, Company Sales (US$ m), Sales in the market (US$ m), Business segment in the market, HQ, No. of Employees, Website)
Table 6.19 Pharmonix Product Portfolio 2020
List of Figures
Figure 1.1 Global Biopharmaceutical Excipient Market Forecast 2020-2030 (US$ m, AGR %)
Figure 1.2 Global Biopharmaceutical Excipients Market Segmentation
Figure 3.1 US Healthcare Expenditure, 1970-2017 (Billion)
Figure 3.2 Benefits provided by business collaborations
Figure 4.1 Global Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 4.2 Global Biopharmaceuticals Excipients Market Forecast by Solubilizers & Surfactants/Emulsifiers 2020-2030 (US$m, Global AGR %)
Figure 4.3 Global Biopharmaceuticals Excipients Market Forecast by Triglycerides 2020-2030 (US$m, Global AGR %)
Figure 4.4 Global Biopharmaceuticals Excipients Market Forecast by Esters 2020-2030 (US$m, Global AGR %)
Figure 4.5 Global Biopharmaceuticals Excipients Market Forecast by Others 2020-2030 (US$m, Global AGR %)
Figure 4.6 Global Biopharmaceuticals Excipients Market Forecast by Polyols 2020-2030 (US$m, Global AGR %)
Figure 4.7 Global Biopharmaceuticals Excipients Market Forecast by Mannitol 2020-2030 (US$m, Global AGR %)
Figure 4.8 Global Biopharmaceuticals Excipients Market Forecast by Sorbitol 2020-2030 (US$m, Global AGR %)
Figure 4.9 Global Biopharmaceuticals Excipients Market Forecast by Others 2020-2030 (US$m, Global AGR %)
Figure 4.10 Global Biopharmaceuticals Excipients Market Forecast by Carbohydrates 2020-2030 (US$m, Global AGR %)
Figure 4.11 Global Biopharmaceuticals Excipients Market Forecast by Sucrose 2020-2030 (US$m, Global AGR %)
Figure 4.12 Global Biopharmaceuticals Excipients Market Forecast by Dextrose 2020-2030 (US$m, Global AGR %)
Figure 4.13 Global Biopharmaceuticals Excipients Market Forecast by Starch 2020-2030 (US$m, Global AGR %)
Figure 4.14 Global Biopharmaceuticals Excipients Market Forecast by Others 2020-2030 (US$m, Global AGR %)
Figure 4.15 Global Biopharmaceuticals Excipients Market Forecast by Specialty Biopharmaceutical Excipients 2020-2030 (US$m, Global AGR %)
Figure 5.1 North America Biopharmaceutical Excipient Markets Forecast by Country 2020-2030 (US$m, AGR %, Cumulative)
Figure 5.2 Europe Biopharmaceutical Excipient Markets Forecast by Country 2020-2030 (US$m, AGR %, Cumulative)
Figure 5.3 Asia Pacific Biopharmaceutical Excipient Markets Forecast by Country 2020-2030 (US$m, AGR %, Cumulative)
Figure 5.4 Rest of World Biopharmaceutical Excipient Markets Forecast by Country 2020-2030 (US$m, AGR %, Cumulative)
Figure 5.5 Canada Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.6 US Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.7 Germany Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.8 France Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.9 UK Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.10 Italy Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.11 Spain Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.12 China Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.13 Australia Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.14 India Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.15 Indonesia Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.16 South Korea Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.17 Rest of Asia Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.18 Middle East Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.19 Africa Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
Figure 5.20 Rest of the World Biopharmaceuticals Excipients Market Forecast by Product (US$m, Global AGR %)
ABITEC Corp
Aventis Behring L.L.C
BASF
BASF SE
Bio Products Laboratory
Biogen
Cambrex
Captisol
Celltrion
Clariant AG
Colorcon
Coriolis Pharma
CSL Behring GmbH
DMV-Fonterra Excipients GmbH & Co. KG
EMA
Emergent BioDefense Operations Lansing, Inc
Evonik Industries AG
Gattefossé
Genetics Institute, Inc
Grifols Biologicals, Inc
GTC Biotherapeutics, Inc
International Conference of Drug Regulatory Authorities (ICDRA)
International Council for Harmonization (ICH)
Kedrion Biopharmaceuticals, SpA
MEGGLE AG
Merck
Novo Nordisk
Octapharma USA, Inc
Pan American Network for Drug Regulatory Harmonization (PANDRH)
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
